Trial Profile
Does cerebral hypoperfusion play a role in reduced axonal metabolism and clinical disability in patients with multiple sclerosis ?
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2018
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- Acronyms ROCHIMS
- 19 Feb 2018 New trial record